Financial results - YRMA PHARM SRL

Financial Summary - Yrma Pharm Srl
Unique identification code: 21227120
Registration number: J22/594/2007
Nace: 7311
Sales - Ron
-
Net Profit - Ron
-1.467
Employee
The most important financial indicators for the company Yrma Pharm Srl - Unique Identification Number 21227120: sales in 2023 was - euro, registering a net profit of -1.467 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati ale agentiilor de publicitate having the NACE code 7311.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Yrma Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 8.215 1.848 0 6.963 6.047 8.751 0 0 0 0
Total Income - EUR 8.215 1.856 0 6.974 6.054 8.751 0 0 0 0
Total Expenses - EUR 2.732 1.986 1.041 564 1.410 3.897 186 169 233 1.467
Gross Profit/Loss - EUR 5.483 -131 -1.041 6.410 4.644 4.853 -186 -169 -233 -1.467
Net Profit/Loss - EUR 5.237 -186 -1.041 6.201 4.462 4.591 -186 -169 -233 -1.467
Employees 2 1 0 0 1 1 1 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Yrma Pharm Srl

Rating financiar

Financial Rating -
Yrma Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Yrma Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Yrma Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Yrma Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Yrma Pharm Srl - CUI 21227120

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 68 4 372 366 0 0 0 0 0 0
Current Assets 7.097 6.596 4.271 10.063 14.364 18.758 18.134 17.563 17.384 15.865
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 1.202 1.212 1.200 7.939 13.341 18.326 17.841 17.416 17.402 15.883
Cash 5.895 5.384 3.071 2.124 1.022 432 292 147 -18 -18
Shareholders Funds 5.171 5.028 3.936 10.070 14.348 18.661 18.120 17.550 17.371 15.852
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 1.993 1.571 707 358 16 97 13 13 13 13
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "7311 - 7311"
CAEN Financial Year 7312
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 15.865 euro in 2023 which includes Inventories of 0 euro, Receivables of 15.883 euro and cash availability of -18 euro.
The company's Equity was valued at 15.852 euro, while total Liabilities amounted to 13 euro. Equity decreased by -1.467 euro, from 17.371 euro in 2022, to 15.852 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Yrma Pharm Srl

Comments - Yrma Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.